Genovate Biotechnology Temettü
Temettü kriter kontrolleri 0/6
Genovate Biotechnology is a dividend paying company with a current yield of 0.65%.
Anahtar bilgiler
0.7%
Temettü verimi
-1.5%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | -0.9% |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | -0.2% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | NT$0.146 |
| Ödeme oranı | 60% |
Son temettü güncellemeleri
Recent updates
Reflecting on Genovate Biotechnology's (GTSM:4130) Share Price Returns Over The Last Five Years
Mar 09
Does It Make Sense To Buy Genovate Biotechnology Co., Ltd. (GTSM:4130) For Its Yield?
Feb 10Genovate Biotechnology Co., Ltd.'s (GTSM:4130) Dismal Stock Performance Reflects Weak Fundamentals
Jan 04
How Much Did Genovate Biotechnology's(GTSM:4130) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 08Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 4130 is not paying a notable dividend for the TW market, therefore no need to check if payments are stable.
Büyüyen Temettü: 4130 is not paying a notable dividend for the TW market, therefore no need to check if payments are increasing.
Piyasaya Karşı Temettü Getirisi
| Genovate Biotechnology Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (4130) | 0.7% |
| Pazarın Alt %25'i (TW) | 1.7% |
| Pazarın En İyi %25'i (TW) | 4.4% |
| Sektör Ortalaması (Pharmaceuticals) | 2.2% |
| Analist tahmini (4130) (3 yıla kadar) | n/a |
Önemli Temettü: 4130's dividend (0.65%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.71%).
Yüksek Temettü: 4130's dividend (0.65%) is low compared to the top 25% of dividend payers in the TW market (4.42%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: 4130 is not paying a notable dividend for the TW market.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: 4130 is not paying a notable dividend for the TW market.